Guardant Health Stock Fundamentals
| GH Stock | USD 48.12 1.14 2.43% |
Guardant Health fundamentals help investors to digest information that contributes to Guardant Health's financial success or failures. It also enables traders to predict the movement of Guardant Stock. The fundamental analysis module provides a way to measure Guardant Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Guardant Health stock.
As of now, Guardant Health's Depreciation And Amortization is increasing as compared to previous years. The Guardant Health's current Selling And Marketing Expenses is estimated to increase to about 356.5 M, while Interest Expense is projected to decrease to under 2.8 M. Guardant | Select Account or Indicator |
Guardant Health Company Profit Margin Analysis
Guardant Health's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Guardant Health Profit Margin | (0.74) % |
Most of Guardant Health's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Guardant Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Guardant Pretax Profit Margin
Pretax Profit Margin |
|
Based on the latest financial disclosure, Guardant Health has a Profit Margin of -0.7402%. This is 93.4% lower than that of the Health Care Providers & Services sector and 93.62% lower than that of the Health Care industry. The profit margin for all United States stocks is 41.72% lower than that of the firm.
Guardant Health Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Guardant Health's current stock value. Our valuation model uses many indicators to compare Guardant Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Guardant Health competition to find correlations between indicators driving Guardant Health's intrinsic value. More Info.Guardant Health is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, Guardant Health's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Guardant Health's earnings, one of the primary drivers of an investment's value.Guardant Health's Earnings Breakdown by Geography
Guardant Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Guardant Health's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Guardant Health could also be used in its relative valuation, which is a method of valuing Guardant Health by comparing valuation metrics of similar companies.Guardant Health is currently under evaluation in profit margin category among its peers.
Guardant Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Guardant Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Guardant Health's managers, analysts, and investors.Environmental | Governance | Social |
Guardant Fundamentals
| Return On Equity | -6.09 | ||||
| Return On Asset | -0.16 | ||||
| Profit Margin | (0.74) % | ||||
| Operating Margin | (0.61) % | ||||
| Current Valuation | 6.29 B | ||||
| Shares Outstanding | 123.56 M | ||||
| Shares Owned By Insiders | 4.73 % | ||||
| Shares Owned By Institutions | 98.23 % | ||||
| Number Of Shares Shorted | 5.77 M | ||||
| Price To Earning | (12.01) X | ||||
| Price To Book | 55.67 X | ||||
| Price To Sales | 8.59 X | ||||
| Revenue | 563.95 M | ||||
| Gross Profit | 417.53 M | ||||
| EBITDA | (433.31 M) | ||||
| Net Income | (479.45 M) | ||||
| Cash And Equivalents | 853.69 M | ||||
| Cash Per Share | 8.35 X | ||||
| Total Debt | 1.35 B | ||||
| Debt To Equity | 4.32 % | ||||
| Current Ratio | 6.18 X | ||||
| Book Value Per Share | (0.49) X | ||||
| Cash Flow From Operations | (324.98 M) | ||||
| Short Ratio | 2.26 X | ||||
| Earnings Per Share | (4.28) X | ||||
| Price To Earnings To Growth | (0.66) X | ||||
| Target Price | 46.76 | ||||
| Number Of Employees | 1.77 K | ||||
| Beta | 1.33 | ||||
| Market Capitalization | 5.95 B | ||||
| Total Asset | 1.79 B | ||||
| Retained Earnings | (2.14 B) | ||||
| Working Capital | 1.14 B | ||||
| Current Asset | 219.68 M | ||||
| Current Liabilities | 24.24 M | ||||
| Net Asset | 1.79 B |
About Guardant Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Guardant Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guardant Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guardant Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 20.7 M | 12.2 M | |
| Total Revenue | 648.5 M | 681 M | |
| Cost Of Revenue | 261.1 M | 274.2 M | |
| Stock Based Compensation To Revenue | 0.14 | 0.16 | |
| Sales General And Administrative To Revenue | 0.32 | 0.51 | |
| Research And Ddevelopement To Revenue | 0.59 | 0.46 | |
| Capex To Revenue | 0.04 | 0.04 | |
| Revenue Per Share | 4.53 | 4.76 | |
| Ebit Per Revenue | (0.90) | (0.95) |
Currently Active Assets on Macroaxis
Check out Guardant Health Piotroski F Score and Guardant Health Altman Z Score analysis. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share | Quarterly Revenue Growth 0.339 | Return On Assets | Return On Equity |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.